Welcome to the Life Sciences blog.

Here you will find articles and insights about life sciences and healthcare.

Без категории
October 12, 2017

The challenge to stay competitive in the API industry
Без категории
October 12, 2017

The 21st Century Gold Rush: Novel Molecular Targets
Без категории
October 11, 2017

Disease Control in Sub-Saharan Africa: Are We Doing Enough?
Без категории
October 10, 2017

CAR T-cell gene therapies enter the U.S. market
Без категории
October 4, 2017

Despite solid API market growth, India and China face challenges – including around costs
Без категории
October 2, 2017

Causality: Taking disease research beyond pathways
Без категории
October 1, 2017

The rise of the biologists: The changing face of the bioinformatics industry
Без категории
September 28, 2017

The mystery of rare diseases
Без категории
September 27, 2017

FDA panel recommends device approval but questions sponsor’s clinical trial change
Без категории
September 21, 2017

Bolstering domestic industry is key pharma focus in Russia
Без категории
September 14, 2017

Biosimilars: opportunities and challenges in the EU, U.S. and Russia
Без категории
August 31, 2017

The blockbuster PARP inhibitor fight intensifies: Focus on ovarian cancer
Без категории
August 23, 2017

Is the FDA’s carrot and stick approach to pediatric drugs working?
Без категории
August 10, 2017

Notable licensing deals in the biopharma industry in Q2 2017
Без категории
August 8, 2017

Second Remicade biosimilar offers glimpse of competitive U.S. market in the future